혈액 분석기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Hematology Analyzers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,919,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,105,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,768,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 혈액 분석기 시장에 대한 광범위한 조사 보고서를 발표하여 원동력, 새로운 동향, 기회, 과제 등 중요한 시장 역학에 대한 종합적인 분석을 제공했습니다. 이 보고서는 시장 상황을 자세히 이해하고 이해 관계자가 정보에 입각한 의사 결정을 내릴 수 있도록 돕습니다.

주요 인사이트

• 혈액 분석기 시장 규모(2024E) : 14억 달러
• 예상 시장 규모(2033F) : 22억 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 5.4%

혈액 분석기 시장 - 보고서 범위:

혈액 분석기 시장에는 혈액 샘플을 분석하여 이상 징후를 감지하고 질병을 진단하며 환자의 건강 상태를 모니터링하는 데 사용되는 다양한 진단 장비가 포함됩니다. 이러한 분석기는 전혈구 계산(CBC), 분별혈구계산, 응고 검사 등 종합적인 혈액 검사를 수행하는 임상 검사실에서 매우 중요합니다. 기술 발전, 정밀 진단에 대한 수요 증가, 질병의 조기 발견에 대한 관심 증가가 이 시장을 주도하고 있습니다.

시장 촉진요인:

혈액 분석기 세계 시장은 혈액 질환의 유병률 증가, 고령화 인구 증가, 혈액 검사 기술의 발전 등 몇 가지 중요한 요인에 의해 활성화되고 있습니다. 보다 빠르고 정확한 검사 결과에 대한 요구로 인해 자동화된 고처리량 분석기에 대한 수요가 증가하고 있습니다. 혈액 분석기에 인공지능(AI)과 머신러닝을 통합하여 진단 능력을 향상시켜 시장 성장을 더욱 촉진하고 있습니다. 또한, 헬스케어 인프라의 확대와 현장 검사(Point-of-Care) 도입 확대도 시장 확대에 기여하고 있습니다.

시장 억제요인:

시장 성장 잠재력에도 불구하고, 혈액 분석기 시장은 고가의 고급 분석기 가격과 복잡한 장비를 조작할 수 있는 숙련된 인력의 필요성이라는 과제에 직면해 있습니다. 또한, 규제 장벽과 엄격한 품질 기준을 준수해야 하는 어려움에 직면해 있습니다. 검사 결과의 정확성과 신뢰성을 확보하는 것은 매우 중요하며, 이 부분에 문제가 발생하면 시장 성장에 영향을 미칠 수 있습니다. 또한, 최신 혈액 분석기에는 초기 투자 비용이 많이 들기 때문에 특히 소규모 의료 시설에 있어서는 장벽이 될 수 있습니다.

시장 기회:

혈액 분석기 시장은 기술 혁신과 헬스케어 투자 증가로 인해 큰 비즈니스 기회를 맞이하고 있습니다. 소형 휴대용 분석기 시장 개척과 차세대 시퀀서 기술의 도입은 시장 성장의 새로운 길을 열어주고 있습니다. 예방 의료 및 조기 진단의 증가는 첨단 혈액학 검사 솔루션에 대한 수요를 촉진하고 있습니다. 전략적 파트너십, 소프트웨어 통합의 발전, 연구개발에 대한 투자는 이러한 기회를 활용하고 시장에서의 입지를 확대하고자 하는 기업에게 필수적입니다.

본 보고서에서 다루는 주요 질문들

• 혈액 분석기 시장의 세계 성장을 촉진하는 주요 요인은 무엇인가?
• 혈액 분석기 채택을 주도하는 애플리케이션과 지역은 어디인가?
• 기술 발전은 혈액 분석기 시장의 경쟁 구도를 어떻게 변화시키고 있는가?
• 혈액 분석기 시장의 주요 플레이어는 누구이며 경쟁력을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 혈액분석기 세계 시장의 새로운 트렌드와 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품 혁신/개발 동향

제4장 핵심성공요인

• 제품 채용/사용 상황 분석
• 제품 USP/특징
• 규제 시나리오
• 기술 평가
• 밸류체인 분석
• 최근의 제품 승인과 발매
• PESTLE 분석
• Porters 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 역학

제6장 COVID-19 위기 - 영향 평가

• COVID-19와 영향 분석
  • 제품별
  • 모달리티별
  • 최종사용자별
  • 지역별
• 2024년 시장 시나리오

제7장 세계 시장 규모(수량) 분석

• 시장(수량) 분석, 2019-2023년
• 시장(수량) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제8장 세계 시장 - 가격 분석

• 제품별 지역별 가격 분석
• 가격 내역
  • 제조업체 레벨 가격 설정
  • 유통업체 레벨 가격 설정
• 세계 평균 가격 분석 벤치마크
• 가격 설정 가정

제9장 세계 시장 수요(금액 및 규모) 분석

• 시장(금액) 분석, 2019-2023년
• 시장(금액) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대적 수익 기회

제10장 제품별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액 및 수량) 분석, 2019-2023년
• 시장 규모(금액 및 수량) 분석과 예측, 2024-2033년
  • 3부 구성 분석기
  • 5부 구성 분석기
  • 기타
• 시장 매력 분석

제11장 모달리티별 : 세계 시장 분석별

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 독립형
  • POC(Point of Care)
• 시장 매력 분석

제12장 최종사용자별 : 세계 시장 분석

• 소개/주요 조사 결과
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 병원
  • 진단 센터
  • 외래 수술 센터
  • 혈액은행
• 시장 매력 분석

제13장 지역별 : 세계 시장 분석

• 소개
• 시장 규모(금액) 분석, 2019-2023년
• 시장 규모(금액) 분석과 예측, 2024-2033년
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카(MEA)
• 시장 매력 분석

제14장 북미 시장 분석

제15장 라틴아메리카 시장 분석

제16장 유럽 시장 분석

제17장 남아시아 시장 분석

제18장 동아시아 시장 분석

제19장 오세아니아 시장 분석

제20장 중동 및 아프리카 시장 분석

제21장 시장 구조 분석

• 기업 계층별 시장 분석
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제22장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세
  • SYSMAX CORPORATION
  • Abbott Laboratories
  • Beckman Coulter Inc
  • Siemens AG
  • Boule Diagnostics AB.
  • Nihon Kohden Corporation
  • Mindray
  • HORIBA Ltd.
  • Diatron
  • Cellavision
  • Edan Instrumnets, Inc
  • SAMSUNG
  • Biosystems SA
  • F. Hoffmann-La Roche Ltd.
  • Shenzhen Dymind Biotechnology Co. Ltd.
  • PZ CORMAY SA
  • PixCell
  • Shenzhen Landwind Insdustry Co. Ltd.
  • Rayto Life and Analytical Sciences Co. Ltd
  • Shenzen Prokan Electronics Inc.

제23장 사용되는 가정과 두문자어

제24장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently published an extensive report on the global Hematology Analyzers Market, offering a comprehensive analysis of critical market dynamics, including driving forces, emerging trends, opportunities, and challenges. This report provides a detailed understanding of the market landscape, assisting stakeholders in making informed decisions.

Key Insights:

• Hematology Analyzers Market Size (2024E): USD 1.4 Bn
• Projected Market Value (2033F): USD 2.2 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 5.4%

Hematology Analyzers Market - Report Scope:

The Hematology Analyzers Market includes a variety of diagnostic devices used for analyzing blood samples to detect abnormalities, diagnose diseases, and monitor patient health. These analyzers are crucial in clinical laboratories for comprehensive blood tests, including complete blood counts (CBC), differential blood counts, and coagulation studies. The market is driven by advancements in technology, increasing demand for precise diagnostics, and a growing focus on early disease detection.

Market Growth Drivers:

The global Hematology Analyzers Market is fueled by several key factors, including the rising prevalence of blood disorders, an increasing aging population, and advancements in hematology technology. The demand for automated and high-throughput analyzers is growing, driven by the need for faster and more accurate test results. The integration of artificial intelligence (AI) and machine learning into hematology analyzers is enhancing diagnostic capabilities, further boosting market growth. Additionally, the expansion of healthcare infrastructure and the rising adoption of point-of-care testing are contributing to the market's expansion.

Market Restraints:

Despite its growth potential, the Hematology Analyzers Market faces challenges such as high costs of advanced analyzers and the need for skilled personnel to operate complex equipment. The market also encounters regulatory hurdles and the need for compliance with stringent quality standards. Ensuring the accuracy and reliability of test results is critical, and any issues in this regard could impact market growth. Additionally, the high initial investment required for state-of-the-art hematology analyzers may pose a barrier, especially for smaller healthcare facilities.

Market Opportunities:

The Hematology Analyzers Market presents significant opportunities driven by technological innovations and increasing healthcare investments. The development of compact, portable analyzers and the introduction of next-generation sequencing technologies are opening new avenues for market growth. The rise in preventive healthcare and early diagnosis is driving demand for advanced hematology testing solutions. Strategic partnerships, advancements in software integration, and investments in research and development are essential for companies aiming to leverage these opportunities and expand their market presence.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the Hematology Analyzers Market globally?
• Which applications and regions are leading the adoption of hematology analyzers?
• How are technological advancements reshaping the competitive landscape of the Hematology Analyzers Market?
• Who are the key players in the Hematology Analyzers Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global Hematology Analyzers Market?

Competitive Intelligence and Business Strategy:

Leading companies in the global Hematology Analyzers Market, such as Abbott Laboratories, Sysmex Corporation, and Beckman Coulter, are focusing on innovation, technological advancements, and strategic partnerships to maintain a competitive edge. These companies are investing in research and development to enhance the capabilities of hematology analyzers, improve diagnostic accuracy, and streamline operations. Collaborations with healthcare providers, technology firms, and research institutions are vital for expanding market reach and driving the adoption of advanced hematology solutions. Emphasizing user-friendly designs, robust performance, and regulatory compliance are key strategies for sustaining leadership in the rapidly evolving Hematology Analyzers Market.

Key Companies Profiled:

• SYSMAX CORPORATION
• Abbott Laboratories
• Beckman Coulter Inc
• Siemens AG
• Boule Diagnostics AB.
• Nihon Kohden Corporation
• Mindray
• HORIBA Ltd.
• Diatron
• Cellavision
• Edan Instrumnets, Inc
• SAMSUNG
• Biosystems SA
• F. Hoffmann-La Roche Ltd.
• Shenzhen Dymind Biotechnology Co. Ltd.
• PZ CORMAY SA
• PixCell
• Shenzhen Landwind Insdustry Co. Ltd.
• Rayto Life and Analytical Sciences Co. Ltd
• Shenzen Prokan Electronics Inc.

Key Segments Covered in Hematology Analyzers Industry Research

Product:

• 3-Part
• 5-Part

Modality:

• Standalone
• Point of Care

End User:

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers
• Blood Banks

Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Regulatory Scenario
• 4.4. Technology Assessment
• 4.5. Value Chain Analysis
• 4.6. Recent Product Approval and Launches
• 4.7. PESTLE Analysis
• 4.8. Porter Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Global Haematology Diagnostics Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Growth of the Top Companies
  • 5.2.2. Technological Advancements
  • 5.2.3. Rising Prevalence of Blood Related Disorders
  • 5.2.4. Cost of the Products
  • 5.2.5. Product and Stock Availability
  • 5.2.6. Increasing Cases of Non-Communicable Diseases and Thalassemia
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis - Impact Assessment

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Modality
  • 6.1.3. BY End User
  • 6.1.4. By Region
• 6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Volume (in Units) Analysis, 2019-2023
• 7.2. Current and Future Volume (in Units) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

• 8.1. Regional Pricing Analysis By Product
• 8.2. Pricing Break-up
  • 8.2.1. Manufacturer Level Pricing
  • 8.2.2. Distributor Level Pricing
• 8.3. Global Average Pricing Analysis Benchmark
• 8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 9.2.1. Y-o-Y Growth Trend Analysis
  • 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
  • 10.3.1. 3-Part Analyzers
  • 10.3.2. 5-Part Analyzers
  • 10.3.3. Others
• 10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis By Modality, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Modality, 2024-2033
  • 11.3.1. Standalone
  • 11.3.2. Point of Care
• 11.4. Market Attractiveness Analysis By Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, by End User

• 12.1. Introduction / Key Findings
• 12.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 12.3.1. Hospitals
  • 12.3.2. Diagnostic Centers
  • 12.3.3. Ambulatory Surgical Centers
  • 12.3.4. Blood Banks
• 12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 13.3.1. North America
  • 13.3.2. Latin America
  • 13.3.3. Europe
  • 13.3.4. South Asia
  • 13.3.5. East Asia
  • 13.3.6. Oceania
  • 13.3.7. Middle East and Africa (MEA)
• 13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. U.S.
    • 14.3.1.2. Canada
  • 14.3.2. By Product
  • 14.3.3. By Modality
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Modality
  • 14.4.4. By End User
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. U.S. Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Product
      • 14.5.1.2.2. By Modality
      • 14.5.1.2.3. By End User
  • 14.5.2. Canada Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Product
      • 14.5.2.2.2. By Modality
      • 14.5.2.2.3. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. Brazil
    • 15.3.1.2. Mexico
    • 15.3.1.3. Argentina
    • 15.3.1.4. Rest of Latin America
  • 15.3.2. By Modality
  • 15.3.3. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Modality
  • 15.4.4. By End User
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. Brazil Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Product
      • 15.5.1.2.2. By Modality
      • 15.5.1.2.3. By End User
  • 15.5.2. Mexico Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Product
      • 15.5.2.2.2. By Modality
      • 15.5.2.2.3. By End User
  • 15.5.3. Argentina Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Product
      • 15.5.3.2.2. By Modality
      • 15.5.3.2.3. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. France
    • 16.3.1.3. Italy
    • 16.3.1.4. U.K.
    • 16.3.1.5. Spain
    • 16.3.1.6. Russia
    • 16.3.1.7. BENELUX
    • 16.3.1.8. Nordic Countries
    • 16.3.1.9. Rest of Europe
  • 16.3.2. By Product
  • 16.3.3. By Modality
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Modality
  • 16.4.4. By End User
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. Germany Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Product
      • 16.5.1.2.2. By Modality
      • 16.5.1.2.3. By End User
  • 16.5.2. France Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Product
      • 16.5.2.2.2. By Modality
      • 16.5.2.2.3. By End User
  • 16.5.3. Italy Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Product
      • 16.5.3.2.2. By Modality
      • 16.5.3.2.3. By End User
  • 16.5.4. U.K. Market Analysis
    • 16.5.4.1. Introduction
    • 16.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.4.2.1. By Product
      • 16.5.4.2.2. By Modality
      • 16.5.4.2.3. By End User
  • 16.5.5. Spain Market Analysis
    • 16.5.5.1. Introduction
    • 16.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.5.2.1. By Product
      • 16.5.5.2.2. By Modality
      • 16.5.5.2.3. By End User
  • 16.5.6. Russia Market Analysis
    • 16.5.6.1. Introduction
    • 16.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.6.2.1. By Product
      • 16.5.6.2.2. By Modality
      • 16.5.6.2.3. By End User
  • 16.5.7. Nordic Countries Market Analysis
    • 16.5.7.1. Introduction
    • 16.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.7.2.1. By Product
      • 16.5.7.2.2. By Modality
      • 16.5.7.2.3. By End User
  • 16.5.8. BENELUX Market Analysis
    • 16.5.8.1. Introduction
    • 16.5.8.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.8.2.1. By Product
      • 16.5.8.2.2. By Modality
      • 16.5.8.2.3. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. India
    • 17.3.1.2. Thailand
    • 17.3.1.3. Indonesia
    • 17.3.1.4. Malaysia
    • 17.3.1.5. Rest of South Asia
  • 17.3.2. By Product
  • 17.3.3. By Modality
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Modality
  • 17.4.4. By End User
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. India Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Product
      • 17.5.1.2.2. By Modality
      • 17.5.1.2.3. By End User
  • 17.5.2. Thailand Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Product
      • 17.5.2.2.2. By Modality
      • 17.5.2.2.3. By End User
  • 17.5.3. Indonesia Market Analysis
    • 17.5.3.1. Introduction
    • 17.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.3.2.1. By Product
      • 17.5.3.2.2. By Modality
      • 17.5.3.2.3. By End User
  • 17.5.4. Malaysia Market Analysis
    • 17.5.4.1. Introduction
    • 17.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.4.2.1. By Product
      • 17.5.4.2.2. By Modality
      • 17.5.4.2.3. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Country
    • 18.3.1.1. China
    • 18.3.1.2. Japan
    • 18.3.1.3. South Korea
  • 18.3.2. By Product
  • 18.3.3. By Modality
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Modality
  • 18.4.4. By End User
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. China Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Product
      • 18.5.1.2.2. By Modality
      • 18.5.1.2.3. By End User
  • 18.5.2. Japan Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Product
      • 18.5.2.2.2. By Modality
      • 18.5.2.2.3. By End User
  • 18.5.3. South Korea Market Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Product
      • 18.5.3.2.2. By Modality
      • 18.5.3.2.3. By End User
• 18.6. Market Trends
• 18.7. Key Market Participants - Intensity Mapping
• 18.8. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Country
    • 19.3.1.1. Australia
    • 19.3.1.2. New Zealand
  • 19.3.2. By Product
  • 19.3.3. By Modality
  • 19.3.4. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Country
  • 19.4.2. By Product
  • 19.4.3. By Modality
  • 19.4.4. By End User
• 19.5. Country Level Analysis & Forecast
  • 19.5.1. Australia Market Analysis
    • 19.5.1.1. Introduction
    • 19.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.1.2.1. By Product
      • 19.5.1.2.2. By Modality
      • 19.5.1.2.3. By End User
  • 19.5.2. New Zealand Market Analysis
    • 19.5.2.1. Introduction
    • 19.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 19.5.2.2.1. By Product
      • 19.5.2.2.2. By Modality
      • 19.5.2.2.3. By End User
• 19.6. Market Trends
• 19.7. Key Market Participants - Intensity Mapping
• 19.8. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 20.3.1. By Country
    • 20.3.1.1. GCC Countries
    • 20.3.1.2. Turkiye
    • 20.3.1.3. Northern Africa
    • 20.3.1.4. South Africa
    • 20.3.1.5. Rest of Middle East and Africa
  • 20.3.2. By Product
  • 20.3.3. By Modality
  • 20.3.4. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Country
  • 20.4.2. By Product
  • 20.4.3. By Modality
  • 20.4.4. By End User
• 20.5. Country Level Analysis & Forecast
  • 20.5.1. GCC Countries Market Analysis
    • 20.5.1.1. Introduction
    • 20.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.1.2.1. By Product
      • 20.5.1.2.2. By Modality
      • 20.5.1.2.3. By End User
  • 20.5.2. Turkiye Market Analysis
    • 20.5.2.1. Introduction
    • 20.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.2.2.1. By Product
      • 20.5.2.2.2. By Modality
      • 20.5.2.2.3. By End User
  • 20.5.3. Northern Africa Market Analysis
    • 20.5.3.1. Introduction
    • 20.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.3.2.1. By Product
      • 20.5.3.2.2. By Modality
      • 20.5.3.2.3. By End User
  • 20.5.4. South Africa Market Analysis
    • 20.5.4.1. Introduction
    • 20.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 20.5.4.2.1. By Product
      • 20.5.4.2.2. By Modality
      • 20.5.4.2.3. By End User
• 20.6. Market Trends
• 20.7. Key Market Participants - Intensity Mapping
• 20.8. Drivers and Restraints - Impact Analysis

21. Market Structure Analysis

• 21.1. Market Analysis by Tier of Companies
• 21.2. Market Share Analysis of Top Players
• 21.3. Market Presence Analysis

22. Competition Analysis

• 22.1. Competition Dashboard
• 22.2. Competition Benchmarking
• 22.3. Competition Deep Dive
  • 22.3.1. SYSMAX CORPORATION
    • 22.3.1.1. Overview
    • 22.3.1.2. Product Portfolio
    • 22.3.1.3. Key Financials
    • 22.3.1.4. SWOT Analysis
    • 22.3.1.5. Sales Footprint
    • 22.3.1.6. Strategy Overview
      • 22.3.1.6.1. Marketing Strategy
      • 22.3.1.6.2. Product Strategy
      • 22.3.1.6.3. Channel Strategy
  • 22.3.2. Abbott Laboratories
    • 22.3.2.1. Overview
    • 22.3.2.2. Product Portfolio
    • 22.3.2.3. Key Financials
    • 22.3.2.4. SWOT Analysis
    • 22.3.2.5. Sales Footprint
    • 22.3.2.6. Strategy Overview
      • 22.3.2.6.1. Marketing Strategy
      • 22.3.2.6.2. Product Strategy
      • 22.3.2.6.3. Channel Strategy
  • 22.3.3. Beckman Coulter Inc
    • 22.3.3.1. Overview
    • 22.3.3.2. Product Portfolio
    • 22.3.3.3. Key Financials
    • 22.3.3.4. SWOT Analysis
    • 22.3.3.5. Sales Footprint
    • 22.3.3.6. Strategy Overview
      • 22.3.3.6.1. Marketing Strategy
      • 22.3.3.6.2. Product Strategy
      • 22.3.3.6.3. Channel Strategy
  • 22.3.4. Siemens AG
    • 22.3.4.1. Overview
    • 22.3.4.2. Product Portfolio
    • 22.3.4.3. Key Financials
    • 22.3.4.4. SWOT Analysis
    • 22.3.4.5. Sales Footprint
    • 22.3.4.6. Strategy Overview
      • 22.3.4.6.1. Marketing Strategy
      • 22.3.4.6.2. Product Strategy
      • 22.3.4.6.3. Channel Strategy
  • 22.3.5. Boule Diagnostics AB.
    • 22.3.5.1. Overview
    • 22.3.5.2. Product Portfolio
    • 22.3.5.3. Key Financials
    • 22.3.5.4. SWOT Analysis
    • 22.3.5.5. Sales Footprint
    • 22.3.5.6. Strategy Overview
      • 22.3.5.6.1. Marketing Strategy
      • 22.3.5.6.2. Product Strategy
      • 22.3.5.6.3. Channel Strategy
  • 22.3.6. Nihon Kohden Corporation
    • 22.3.6.1. Overview
    • 22.3.6.2. Product Portfolio
    • 22.3.6.3. Key Financials
    • 22.3.6.4. SWOT Analysis
    • 22.3.6.5. Sales Footprint
    • 22.3.6.6. Strategy Overview
      • 22.3.6.6.1. Marketing Strategy
      • 22.3.6.6.2. Product Strategy
      • 22.3.6.6.3. Channel Strategy
  • 22.3.7. Mindray
    • 22.3.7.1. Overview
    • 22.3.7.2. Product Portfolio
    • 22.3.7.3. Key Financials
    • 22.3.7.4. SWOT Analysis
    • 22.3.7.5. Sales Footprint
    • 22.3.7.6. Strategy Overview
      • 22.3.7.6.1. Marketing Strategy
      • 22.3.7.6.2. Product Strategy
      • 22.3.7.6.3. Channel Strategy
  • 22.3.8. HORIBA Ltd.
    • 22.3.8.1. Overview
    • 22.3.8.2. Product Portfolio
    • 22.3.8.3. Key Financials
    • 22.3.8.4. SWOT Analysis
    • 22.3.8.5. Sales Footprint
    • 22.3.8.6. Strategy Overview
      • 22.3.8.6.1. Marketing Strategy
      • 22.3.8.6.2. Product Strategy
      • 22.3.8.6.3. Channel Strategy
  • 22.3.9. Diatron
    • 22.3.9.1. Overview
    • 22.3.9.2. Product Portfolio
    • 22.3.9.3. Key Financials
    • 22.3.9.4. SWOT Analysis
    • 22.3.9.5. Sales Footprint
    • 22.3.9.6. Strategy Overview
      • 22.3.9.6.1. Marketing Strategy
      • 22.3.9.6.2. Product Strategy
      • 22.3.9.6.3. Channel Strategy
  • 22.3.10. Cellavision
    • 22.3.10.1. Overview
    • 22.3.10.2. Product Portfolio
    • 22.3.10.3. Key Financials
    • 22.3.10.4. SWOT Analysis
    • 22.3.10.5. Sales Footprint
    • 22.3.10.6. Strategy Overview
      • 22.3.10.6.1. Marketing Strategy
      • 22.3.10.6.2. Product Strategy
      • 22.3.10.6.3. Channel Strategy
  • 22.3.11. Edan Instrumnets, Inc
    • 22.3.11.1. Overview
    • 22.3.11.2. Product Portfolio
    • 22.3.11.3. Key Financials
    • 22.3.11.4. SWOT Analysis
    • 22.3.11.5. Sales Footprint
    • 22.3.11.6. Strategy Overview
      • 22.3.11.6.1. Marketing Strategy
      • 22.3.11.6.2. Product Strategy
      • 22.3.11.6.3. Channel Strategy
  • 22.3.12. SAMSUNG
    • 22.3.12.1. Overview
    • 22.3.12.2. Product Portfolio
    • 22.3.12.3. Key Financials
    • 22.3.12.4. SWOT Analysis
    • 22.3.12.5. Sales Footprint
    • 22.3.12.6. Strategy Overview
      • 22.3.12.6.1. Marketing Strategy
      • 22.3.12.6.2. Product Strategy
      • 22.3.12.6.3. Channel Strategy
  • 22.3.13. Biosystems SA
    • 22.3.13.1. Overview
    • 22.3.13.2. Product Portfolio
    • 22.3.13.3. Key Financials
    • 22.3.13.4. SWOT Analysis
    • 22.3.13.5. Sales Footprint
    • 22.3.13.6. Strategy Overview
      • 22.3.13.6.1. Marketing Strategy
      • 22.3.13.6.2. Product Strategy
      • 22.3.13.6.3. Channel Strategy
  • 22.3.14. F. Hoffmann-La Roche Ltd.
    • 22.3.14.1. Overview
    • 22.3.14.2. Product Portfolio
    • 22.3.14.3. Key Financials
    • 22.3.14.4. SWOT Analysis
    • 22.3.14.5. Sales Footprint
    • 22.3.14.6. Strategy Overview
      • 22.3.14.6.1. Marketing Strategy
      • 22.3.14.6.2. Product Strategy
      • 22.3.14.6.3. Channel Strategy
  • 22.3.15. Shenzhen Dymind Biotechnology Co. Ltd.
    • 22.3.15.1. Overview
    • 22.3.15.2. Product Portfolio
    • 22.3.15.3. Key Financials
    • 22.3.15.4. SWOT Analysis
    • 22.3.15.5. Sales Footprint
    • 22.3.15.6. Strategy Overview
      • 22.3.15.6.1. Marketing Strategy
      • 22.3.15.6.2. Product Strategy
      • 22.3.15.6.3. Channel Strategy
  • 22.3.16. PZ CORMAY SA
    • 22.3.16.1. Overview
    • 22.3.16.2. Product Portfolio
    • 22.3.16.3. Key Financials
    • 22.3.16.4. SWOT Analysis
    • 22.3.16.5. Sales Footprint
    • 22.3.16.6. Strategy Overview
      • 22.3.16.6.1. Marketing Strategy
      • 22.3.16.6.2. Product Strategy
      • 22.3.16.6.3. Channel Strategy
  • 22.3.17. PixCell
    • 22.3.17.1. Overview
    • 22.3.17.2. Product Portfolio
    • 22.3.17.3. Key Financials
    • 22.3.17.4. SWOT Analysis
    • 22.3.17.5. Sales Footprint
    • 22.3.17.6. Strategy Overview
      • 22.3.17.6.1. Marketing Strategy
      • 22.3.17.6.2. Product Strategy
      • 22.3.17.6.3. Channel Strategy
  • 22.3.18. Shenzhen Landwind Insdustry Co. Ltd.
    • 22.3.18.1. Overview
    • 22.3.18.2. Product Portfolio
    • 22.3.18.3. Key Financials
    • 22.3.18.4. SWOT Analysis
    • 22.3.18.5. Sales Footprint
    • 22.3.18.6. Strategy Overview
      • 22.3.18.6.1. Marketing Strategy
      • 22.3.18.6.2. Product Strategy
      • 22.3.18.6.3. Channel Strategy
  • 22.3.19. Rayto Life and Analytical Sciences Co. Ltd
    • 22.3.19.1. Overview
    • 22.3.19.2. Product Portfolio
    • 22.3.19.3. Key Financials
    • 22.3.19.4. SWOT Analysis
    • 22.3.19.5. Sales Footprint
    • 22.3.19.6. Strategy Overview
      • 22.3.19.6.1. Marketing Strategy
      • 22.3.19.6.2. Product Strategy
      • 22.3.19.6.3. Channel Strategy
  • 22.3.20. Shenzen Prokan Electronics Inc.
    • 22.3.20.1. Overview
    • 22.3.20.2. Product Portfolio
    • 22.3.20.3. Key Financials
    • 22.3.20.4. SWOT Analysis
    • 22.3.20.5. Sales Footprint
    • 22.3.20.6. Strategy Overview
      • 22.3.20.6.1. Marketing Strategy
      • 22.3.20.6.2. Product Strategy
      • 22.3.20.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology

관련자료